Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability.
暂无分享,去创建一个
[1] G. Liversidge,et al. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs , 1995 .
[2] Rainer H. Müller,et al. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique , 1998 .
[3] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[4] Mitra Mosharraf,et al. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs , 1995 .
[5] S. Mortazavi,et al. An investigation of some factors influencing the in vitro assessment of mucoadhesion , 1995 .
[6] H. Ch'ng,et al. Evaluation of possible mechanism(s) of bioadhesion , 1998 .
[7] R. Laing. Nosocomial infections in patients with HIV disease. , 1999, The Journal of hospital infection.
[8] H. Junginger,et al. Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro , 1997 .
[9] S. Jahnke. The theory of high-pressure homogenization , 2001 .
[10] G. Smistad,et al. Bioadhesion of hydrated chitosans: An in vitro and in vivo study , 1996 .
[11] O. Kayser,et al. A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications. , 2001, International journal of pharmaceutics.
[12] Donald L. Wise,et al. Nanosuspensions: A Formulation Approach for Poorly Soluble and Poorly Bioavailable Drugs , 2000 .
[13] Dominique Duchêne,et al. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract , 1997 .